|
ZNF493 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.615600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.919650E-02 |
| Normal-vs-Stage2 |
4.412000E-01 |
| Normal-vs-Stage3 |
1.65559999998344E-06 |
| Normal-vs-Stage4 |
1.596790E-01 |
| Stage1-vs-Stage2 |
6.061000E-01 |
| Stage1-vs-Stage3 |
1.824770E-03 |
| Stage1-vs-Stage4 |
5.126600E-01 |
| Stage2-vs-Stage3 |
5.138300E-02 |
| Stage2-vs-Stage4 |
4.276600E-01 |
| Stage3-vs-Stage4 |
5.978800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.447660E-02 |
| Normal-vs-AfricanAmerican |
3.831600E-02 |
| Normal-vs-Asian |
1.316040E-01 |
| Caucasian-vs-AfricanAmerican |
9.991400E-01 |
| Caucasian-vs-Asian |
7.515400E-01 |
| AfricanAmerican-vs-Asian |
7.221600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.096800E-03 |
| Normal-vs-Female |
1.049610E-01 |
| Male-vs-Female |
4.832000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.680500E-02 |
| Normal-vs-Extreme_Weight |
5.397200E-03 |
| Normal-vs-Obese |
1.983570E-02 |
| Normal-vs-Extreme_Obese |
9.419200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.291800E-01 |
| Normal_Weight-vs-Obese |
9.409000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.243400E-01 |
| Extreme_Weight-vs-Obese |
7.426800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.588440E-01 |
| Obese-vs-Extreme_Obese |
1.405170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.171600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.505900E-02 |
| Normal-vs-Age(61-80Yrs) |
7.920500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.578020E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.576600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.859200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.746300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.938400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.636700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.917590E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.507180E-01 |
| Normal-VS-Type2 PRCC |
2.27030000021777E-07 |
| Normal-VS-KIRP CIMP |
3.429900E-04 |
| Normal-VS-Unclassified PRCC |
8.127800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.78399999994916E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.441940E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.191000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.453200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.082200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.514100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.298220E-03 |
| Normal-vs-N1 |
1.444090E-02 |
| Normal-vs-N2 |
7.551500E-04 |
| N0-vs-N1 |
9.542600E-01 |
| N0-vs-N2 |
1.144990E-01 |
| N1-vs-N2 |
9.761100E-03 |
|
|
